Biocon reports over five-fold jump in Q3 consolidated net profit

13 Feb 2026 Evaluate

Biocon has reported results for third quarter ended December 31, 2025 (Q3FY26). 

The company has reported a net loss of Rs 76.40 crore for the third quarter ended December 31, 2025 as compared to net profit of Rs 584.00 crore for the same quarter in the previous year. However, the total income of the company increased by 11.02% at Rs 696.10 crore for Q3FY26 as compared to Rs 627.00 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported over five-fold jump in its net profit at Rs 143.80 crore for the third quarter ended December 31, 2025 as compared to Rs 25.10 crore for the same quarter in the previous year. The total income of the company increased by 11.26% at Rs 4,290.30 crore for Q3FY26 as compared to Rs 3,856.20 crore for the corresponding quarter previous year.

Biocon Share Price

377.80 2.55 (0.68%)
13-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1698.10
Dr. Reddys Lab 1267.60
Cipla 1330.85
Zydus Lifesciences 904.85
Lupin 2199.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×